These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
1030 related articles for article (PubMed ID: 20399997)
21. Relative bioavailability of tizanidine 4-mg capsule and tablet formulations after a standardized high-fat meal: a single-dose, randomized, open-label, crossover study in healthy subjects. Henney HR; Shah J Clin Ther; 2007 Apr; 29(4):661-9. PubMed ID: 17617289 [TBL] [Abstract][Full Text] [Related]
22. Comparative bioavailability of 2 tablet formulations of levodopa/benserazide in healthy, fasting volunteers: a single-dose, randomized-sequence, open-label crossover study. Keller GA; Czerniuk P; Bertuola R; Spatz JG; Assefi AR; Di Girolamo G Clin Ther; 2011 Apr; 33(4):500-10. PubMed ID: 21635995 [TBL] [Abstract][Full Text] [Related]
23. Bioequivalence of two levothyroxine tablet formulations without and with mathematical adjustment for basal thyroxine levels in healthy Argentinian volunteers: a single-dose, randomized, open-label, crossover study. Di Girolamo G; Keller GA; de Los Santos AR; Schere D; Gonzalez CD Clin Ther; 2008 Nov; 30(11):2015-23. PubMed ID: 19108789 [TBL] [Abstract][Full Text] [Related]
24. Comparison of the pharmacokinetics of ticlopidine between administration of a combined fixed-dose tablet formulation of ticlopidine 250 mg/ginkgo extract 80 mg, and concomitant administration of ticlopidine 250-mg and ginkgo extract 80-mg tablets: an open-label, two-treatment, single-dose, randomized-sequence crossover study in healthy Korean male volunteers. Kim TE; Kim BH; Kim J; Kim KP; Yi S; Shin HS; Lee YO; Lee KH; Shin SG; Jang IJ; Yu KS Clin Ther; 2009 Oct; 31(10):2249-57. PubMed ID: 19922896 [TBL] [Abstract][Full Text] [Related]
25. The relative bioavailability and fasting pharmacokinetics of three formulations of olmesartan medoxomil 20-mg capsules and tablets in healthy Chinese male volunteers: An open-label, randomized-sequence, single-dose, three-way crossover study. Li KY; Liang JP; Hu BQ; Qiu Y; Luo CH; Jiang Y; Lin XP; Yang N Clin Ther; 2010 Aug; 32(9):1674-80. PubMed ID: 20974325 [TBL] [Abstract][Full Text] [Related]
26. Bioequivalence and pharmacokinetics of two zidovudine formulations in healthy Brazilian volunteers: an open-label, randomized, single-dose, two-way crossover study. Dos Reis Serra CH; Mori Koono EE; Kano EK; Schramm SG; Armando YP; Porta V Clin Ther; 2008 May; 30(5):902-8. PubMed ID: 18555936 [TBL] [Abstract][Full Text] [Related]
27. A phase I, randomized, open-label, crossover study of the single-dose pharmacokinetic properties of guanfacine extended-release 1-, 2-, and 4-mg tablets in healthy adults. Swearingen D; Pennick M; Shojaei A; Lyne A; Fiske K Clin Ther; 2007 Apr; 29(4):617-25. PubMed ID: 17617285 [TBL] [Abstract][Full Text] [Related]
28. Bioequivalence of single and multiple doses of venlafaxine extended-release tablets and capsules in the fasted and fed states: four open-label, randomized crossover trials in healthy volunteers. Wright CW; Aikman MS; Werts E; Seabolt J; Haeusler JM Clin Ther; 2009 Nov; 31(11):2722-34. PubMed ID: 20110014 [TBL] [Abstract][Full Text] [Related]
29. Bioavailability and pharmacokinetic comparison between generic and branded azithromycin capsule: a randomized, double-blind, 2-way crossover in healthy male Thai volunteers. Boonleang J; Panrat K; Tantana C; Krittathanmakul S; Jintapakorn W Clin Ther; 2007 Apr; 29(4):703-10. PubMed ID: 17617293 [TBL] [Abstract][Full Text] [Related]
30. Bioequivalence of generic and branded subcutaneous enoxaparin: a single-dose, randomized-sequence, open-label, two-period crossover study in healthy Chinese male subjects. Feng L; Shen-Tu J; Liu J; Chen J; Wu L; Huang M Clin Ther; 2009 Jul; 31(7):1559-67. PubMed ID: 19695405 [TBL] [Abstract][Full Text] [Related]
31. Bioavailability of two sublingual formulations of ketorolac tromethamine 30 mg: a randomized, open-label, single-dose, two-period crossover comparison in healthy Mexican adult volunteers. Galán-Herrera JF; Poo JL; Maya-Barrios JA; de Lago A; Oliva I; González-de la Parra M; Jiménez P; López-Bojórquez E; Burke-Fraga V; Namur S Clin Ther; 2008 Sep; 30(9):1667-74. PubMed ID: 18840372 [TBL] [Abstract][Full Text] [Related]
32. A randomised, two-period, cross-over, open-label study to evaluate the pharmacokinetic profiles of single doses of two different flurbiprofen 8.75-mg lozenges in healthy volunteers. Matzneller P; Burian A; Martin W; Annoni O; Lauro V; Tacchi R; Brunner M; Zeitlinger M Pharmacology; 2012; 89(3-4):188-91. PubMed ID: 22433300 [TBL] [Abstract][Full Text] [Related]
33. Bioavailability of two oral formulations of azithromycin 500 mg: a randomized, open-label, two-period crossover comparison in healthy Mexican adult subjects. Piñeyro-López A; Pineyro-Garza E; Torres-Alanís O; Reyes-Araiza R; Gómez Silva M; Wacksman N; Rangel RL; de Lago A; González-de la Parra M; Namur S Clin Ther; 2005 Oct; 27(10):1607-11. PubMed ID: 16330296 [TBL] [Abstract][Full Text] [Related]
34. Pharmacokinetic properties of combination oxycodone plus racemic ibuprofen: two randomized, open-label, crossover studies in healthy adult volunteers. Kapil R; Nolting A; Roy P; Fiske W; Benedek I; Abramowitz W Clin Ther; 2004 Dec; 26(12):2015-25. PubMed ID: 15823765 [TBL] [Abstract][Full Text] [Related]
35. Bioequivalence of single 100-mg doses of two oral formulations of topiramate: an open-label, randomized-sequence, two-period crossover study in healthy adult male Mexican volunteers. Piñeyro-López A; Piñeyro-Garza E; Gómez-Silva M; Reyes-Araiza R; Flores-Diego MA; Borrego-Alvarado S; Gamino-Peña ME; Vargas-Zapata R; Salazar-Leal ME Clin Ther; 2009 Feb; 31(2):411-7. PubMed ID: 19302913 [TBL] [Abstract][Full Text] [Related]
36. A randomized, open-label, two-period, crossover bioavailability study of two oral formulations of tacrolimus in healthy Korean adults. Park K; Kim YS; Kwon KI; Park MS; Lee YJ; Kim KH Clin Ther; 2007 Jan; 29(1):154-62. PubMed ID: 17379055 [TBL] [Abstract][Full Text] [Related]
37. Relative bioavailability and pharmacokinetics of a new sibutramine formulation in healthy male subjects: a randomized, open-label, two-period, comparative crossover study. Park JY; Kim KA; Park PW; Suh KH; Lee GS Clin Ther; 2004 Dec; 26(12):2092-101. PubMed ID: 15823773 [TBL] [Abstract][Full Text] [Related]
38. Single-dose bioequivalence of 105-mg fenofibric acid tablets versus 145-mg fenofibrate tablets under fasting and fed conditions: a report of two phase I, open-label, single-dose, randomized, crossover clinical trials. Godfrey AR; Digiacinto J; Davis MW Clin Ther; 2011 Jun; 33(6):766-75. PubMed ID: 21704241 [TBL] [Abstract][Full Text] [Related]
39. Pharmacokinetic and bioequivalence comparison between orally disintegrating and conventional tablet formulations of flurbiprofen: a single-dose, randomized-sequence, open-label, two-period crossover study in healthy Chinese male volunteers. Liu YM; Liu GY; Liu Y; Li SJ; Jia JY; Zhang MQ; Lu C; Zhang YM; Li XN; Yu C Clin Ther; 2009 Aug; 31(8):1787-95. PubMed ID: 19808137 [TBL] [Abstract][Full Text] [Related]
40. Comparative fasting bioavailability of dispersible and conventional tablets of risperidone: a single-dose, randomized-sequence, open-label, two-period crossover study in healthy male Chinese volunteers. Huang M; Shen-Tu J; Hu X; Chen J; Liu J; Wu L Clin Ther; 2012 Jun; 34(6):1432-9. PubMed ID: 22595151 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]